Nightingale Health’s Board of Directors resolved on amendment to CEO’s incentive program
Nightingale Health PlcCompany release20 September 2024 at 1:45 p.m. (EEST) Nightingale Health Plc’s (“Nightingale Health”) Board of Directors has resolved to amend CEO’s stock option program by issuing additional 1,000,000 stock option rights to the CEO. The right to subscribe for shares with the new stock option rights is earned based on reaching the market capitalization of 1,500 million. Each option right entitles the CEO to subscribe for one Series B share. The subscription price of each share is EUR 6.75 per share. The Board of Directors has on 3 March